BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22920712)

  • 1. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.
    Moretti ML; Trabasso P; Lyra L; Fagnani R; Resende MR; de Oliveira Cardoso LG; Schreiber AZ
    Med Mycol; 2013 Apr; 51(3):225-30. PubMed ID: 22920712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.
    Colombo AL; Garnica M; Aranha Camargo LF; Da Cunha CA; Bandeira AC; Borghi D; Campos T; Senna AL; Valias Didier ME; Dias VC; Nucci M
    Med Mycol; 2013 Jan; 51(1):38-44. PubMed ID: 22762208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.
    Girão E; Levin AS; Basso M; Gobara S; Gomes LB; Medeiros EA; Costa SF
    Med Mycol; 2008 Sep; 46(6):581-8. PubMed ID: 19180727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
    Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
    Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
    Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
    Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country.
    Ulu Kilic A; Alp E; Cevahir F; Ture Z; Yozgat N
    Mycoses; 2017 Mar; 60(3):198-203. PubMed ID: 27862414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
    Siopi M; Tarpatzi A; Kalogeropoulou E; Damianidou S; Vasilakopoulou A; Vourli S; Pournaras S; Meletiadis J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt.
    Hegazi M; Abdelkader A; Zaki M; El-Deek B
    J Infect Dev Ctries; 2014 May; 8(5):624-34. PubMed ID: 24820467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
    Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.
    Colombo AL; Guimarães T; Silva LR; de Almeida Monfardini LP; Cunha AK; Rady P; Alves T; Rosas RC
    Infect Control Hosp Epidemiol; 2007 May; 28(5):570-6. PubMed ID: 17464917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.
    Martí-Carrizosa M; Sánchez-Reus F; March F; Coll P
    Scand J Infect Dis; 2014 Jun; 46(6):454-61. PubMed ID: 24762093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
    Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
    PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
    Lin MY; Carmeli Y; Zumsteg J; Flores EL; Tolentino J; Sreeramoju P; Weber SG
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4555-60. PubMed ID: 16251295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing epidemiology of candidemia in a medical center in middle Taiwan.
    Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study.
    Yapar N; Pullukcu H; Avkan-Oguz V; Sayin-Kutlu S; Ertugrul B; Sacar S; Cetin B; Kaya O
    Med Mycol; 2011 Jan; 49(1):26-31. PubMed ID: 20662635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidemia in major burns patients.
    Renau Escrig AI; Salavert M; Vivó C; Cantón E; Pérez Del Caz MD; Pemán J
    Mycoses; 2016 Jun; 59(6):391-8. PubMed ID: 26931414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of epidemiology and prognostic factors for candidemia at a hospital in China, 2000-2009.
    Zhang XB; Yu SJ; Yu JX; Gong YL; Feng W; Sun FJ
    Jpn J Infect Dis; 2012; 65(6):510-5. PubMed ID: 23183203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in patient risk factors and source of candidaemia caused by Candida albicans and Candida glabrata.
    Segireddy M; Johnson LB; Szpunar SM; Khatib R
    Mycoses; 2011 Jul; 54(4):e39-43. PubMed ID: 20051013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.